









Markets
/
Stocks
/
nasdaq-urgn
/

Urogen Pharma Ltd

URGN

View Detailed Chart

4.170USD

-3.370-44.69%

Close 05/21, 16:00（ET）Quotes delayed by 15 min

176.11MMarket Cap

LossP/E TTM



Urogen Pharma Ltd

4.170

-3.370-44.69%

Company

Intraday

30m

Today

-44.69%

5 Days

-57.75%

1 Month

-56.83%

6 Months

-63.90%

Year to Date

-60.85%

1 Year

-68.58%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 8 analysts

BUY

Current Rating

32.625

Target Price

332.69%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

560

Total

Median

Average

Company name

Ratings

Analysts

Urogen Pharma Ltd

URGN

CRISPR Therapeutics AG

CRSP

Regeneron Pharmaceuticals Inc

REGN

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Moderna Inc

MRNA

...

112

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(10)

Neutral(2)

Buy(1)

Indicators

Sell(4)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.700

Sell

RSI(14)

34.968

Neutral

STOCH(KDJ)(9,3,3)

21.788

Neutral

ATR(14)

1.214

High Vlolatility

CCI(14)

-145.052

Sell

Williams %R

79.586

Sell

TRIX(12,20)

-0.502

Sell

StochRSI(14)

25.002

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

8.508

Sell

MA10

9.499

Sell

MA20

10.120

Sell

MA50

10.526

Sell

MA100

10.488

Sell

MA200

11.675

Sell

News

More news coming soon, stay tuned...

Company

UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. The Company is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).

Company codeURGN

CompanyUrogen Pharma Ltd

CEOMs. Elizabeth A. (Liz) Barrett

Websitehttps://www.urogen.com/